Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
At ESC-HFA 2022, Ferinject banner ads ran for 60 days on the congress site/Medscape and reached UK HCPs unintentionally. UK signatory certification…
Anonymous complaint alleged a Guardian-sponsored SOBI corporate article was disguised promotion and misleading. PMCPA Panel ruled no breach of Clauses 3.6, 5.1,…
At ESC-HFA 2022, Ferinject banner ads ran on the congress site/Medscape and unintentionally reached UK HCPs for 60 days without certification by…
A Ferinject promotional article in the British Journal of Cardiology used “safe” in key messages without adequate qualification. Breach of Clause 7.9…
UCB’s Bimzelx leavepiece used in vitro pathway claims and cytokine level data in a way that implied clinical superiority vs IL‑17A inhibitors.…
PMCPA found a Clause 5.1 breach after a UK-based AstraZeneca Global employee ‘liked’ a Reuters/LinkedIn post about Evusheld before UK authorisation. Other…
PMCPA found AbbVie’s Rinvoq RA/PsA webpages misleading: surfing imagery implied unrealistic outcomes and pages didn’t prominently flag pregnancy contraindication/contraception advice for women…
Novartis’ Entresto HCP website claim that national guidelines support 1st line use in chronic HFrEF was ruled insufficiently complete for a broad…
Ex-employee alleged CSL Vifor’s non-promotional NHS service was targeted to Ferinject-using hospitals and amounted to disguised promotion/inducement. Panel found allegations not evidenced…
PMCPA ruled Proveca’s Sialanar dosing calculator app was promotional and had to stand alone. Breaches included missing PI/PI signposting, incorrect AE wording,…
A Tillotts rep made an unplanned GP practice call about Asacol shortage/Octasa switch. The pharmacist said they don’t see reps, but the…
PMCPA found Roche’s Rozlytrek dosing webpage misleading because it omitted key SPC dose-modification/discontinuation guidance for several safety scenarios in a black triangle…
Teva’s Ajovy webinar registration site breached the ABPI Code because the prescribing information link wasn’t sufficiently prominent and the black triangle wasn’t…
A rep supplied Methofill injector training materials to a children’s gastroenterology nurse without immediately stating paediatric Crohn’s use was off-label. Breach of…
MIMS print ad implied all Symbicort strengths could be used for MART, despite 400/12 being maintenance-only, and failed to reference where PI…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
